In breast and pancreatic cancer cells, FAK is assumed to act up-stream of the Wnt/β-catenin pathway [40], while in other systems, FAK acts downstream of Wnt promoting AKT/mTOR activation in vivo and leading to increased intestinal cell proliferation and tumorigenesis [54]. The gene discussed is AKT1; the disease is pancreatic neoplasm.